FR2695388B1 - Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation. - Google Patents

Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation.

Info

Publication number
FR2695388B1
FR2695388B1 FR9310521A FR9310521A FR2695388B1 FR 2695388 B1 FR2695388 B1 FR 2695388B1 FR 9310521 A FR9310521 A FR 9310521A FR 9310521 A FR9310521 A FR 9310521A FR 2695388 B1 FR2695388 B1 FR 2695388B1
Authority
FR
France
Prior art keywords
benzotriazepin
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9310521A
Other languages
English (en)
Other versions
FR2695388A1 (fr
Inventor
Ilona Bodi Dr
Eva Gal Dr
Melinda Gal Dr
Laszlo Jaszlits Dr
Andrea Jednakovits
Adrina Kiss Dr
Aniko Miklos-Nee-Kovacs Dr
Gyorgy Mathe
Istvan Pallagi
Gyorgy Rabloczky Dr
Antal Simai Dr
Endre Tihanyi Dr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2695388A1 publication Critical patent/FR2695388A1/fr
Application granted granted Critical
Publication of FR2695388B1 publication Critical patent/FR2695388B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9310521A 1992-09-04 1993-09-03 Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation. Expired - Fee Related FR2695388B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9202833A HU212266B (en) 1992-09-04 1992-09-04 Process for producing novel 1,3,4-benzotriazepin-5(4h)-one derivatives and pharmaceutical preparations containing them

Publications (2)

Publication Number Publication Date
FR2695388A1 FR2695388A1 (fr) 1994-03-11
FR2695388B1 true FR2695388B1 (fr) 1995-05-24

Family

ID=10982296

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9310521A Expired - Fee Related FR2695388B1 (fr) 1992-09-04 1993-09-03 Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation.

Country Status (14)

Country Link
US (1) US5441948A (fr)
JP (1) JPH06157483A (fr)
KR (1) KR940007008A (fr)
CN (1) CN1087632A (fr)
CH (1) CH686081A5 (fr)
CZ (1) CZ182493A3 (fr)
DE (1) DE4329874A1 (fr)
FI (1) FI933872A (fr)
FR (1) FR2695388B1 (fr)
GB (1) GB2270313B (fr)
HU (1) HU212266B (fr)
IT (1) IT1273981B (fr)
NL (1) NL9301524A (fr)
YU (1) YU58093A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104961747B (zh) * 2015-06-02 2017-10-24 大连理工大学 一种四氢苯并[d][1,2,6]氧杂二氮*类化合物及其制备方法
CN104945403B (zh) * 2015-06-02 2017-07-21 大连理工大学 一种四氢苯并[e][1,2,4]三氮杂*类化合物及其制备方法
CN105037386B (zh) * 2015-06-02 2017-10-24 大连理工大学 一种四氢苯并[c][1,2,5]噁二嗪类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57109772A (en) * 1980-12-27 1982-07-08 Otsuka Pharmaceut Co Ltd Benzotriazepine derivative
US4482547A (en) * 1982-08-26 1984-11-13 Hoechst-Roussel Pharmaceuticals Inc. Substituted-1,3,4-benzotriazepines

Also Published As

Publication number Publication date
FI933872A0 (fi) 1993-09-03
HU212266B (en) 1996-04-29
GB2270313B (en) 1995-07-12
CZ182493A3 (en) 1994-04-13
US5441948A (en) 1995-08-15
ITMI931897A0 (it) 1993-09-03
CN1087632A (zh) 1994-06-08
HU9202833D0 (en) 1992-11-30
IT1273981B (it) 1997-07-14
KR940007008A (ko) 1994-04-26
FR2695388A1 (fr) 1994-03-11
GB2270313A (en) 1994-03-09
CH686081A5 (de) 1995-12-29
YU58093A (sh) 1996-02-19
NL9301524A (nl) 1994-04-05
DE4329874A1 (de) 1994-03-10
JPH06157483A (ja) 1994-06-03
FI933872A (fi) 1994-03-05
ITMI931897A1 (it) 1995-03-03
HUT67062A (en) 1995-01-30
GB9318254D0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
DZ2300A1 (fr) Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr) Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2172A1 (fr) Dérivés de triazole utiles on thérapeutique, procédé pour leur préparation et compositions les contenant.
FR2719587B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ418A1 (fr) Dérivés de céphalosporine, leur procédé de préparation et leur application thérapeutique.
DZ2217A1 (fr) Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
HU902496D0 (en) Process for producing new naphtalenyl-alkyl-3h-1,2,3,5-oxa-thiadiazole derivatives and pharmaceutical preparatives containing these compounds
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
DZ1618A1 (fr) Procédé de préparation de distilmats moyens.
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
OA09442A (fr) Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant.
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
DZ1677A1 (fr) Procédé pour la préparation de composés pour le traitement des troubles neuro-dégénératifs.
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
FR2695388B1 (fr) Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation.
FR2697250B1 (fr) Dérivés de beta,beta-diméthyl-4-pipéridineéthanol et de 1,2,3,6-tétrahydro-beta,beta-diméthyl-4-pyridineéthanol, leur procédé de préparation et leur utilisation en thérapeutique.
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
FR2691464B1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
FR2696745B1 (fr) Procédé de préparation de dérivés de phényltétrazole.
FR2706459B1 (fr) Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
OA09302A (fr) Nouveaux dérivés d'oxazolo pyridines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse